Does an Increased Prevalence Rate of Attention-Deficit Hyperactivity Disorder (ADHD) Exist Among Persons With Albinism?

Klemen, Jane; McAvinue, Laura P.

doi:10.1177/0883073814556311

Cited by 2 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Health professionals, educators and caregivers should be aware of an increased prevalence in attention-deficit disorders, with or without hyperactivity (Attention-Deficit/Hyperactivity Disorder, ADHD) that justifies a neurological assessment and follow-up. 93 The importance of psychological support and the normality of psychomotor development are underlined. 94,95 ENT monitoring Different degrees of hearing impairment have been reported in patients with different albinism subtypes.…”

Section: Neurological and Psychological Monitoringmentioning

confidence: 99%

Management of albinism: French guidelines for diagnosis and care

Moreno‐Artero

Morice‐Picard

Brémond‐Gignac

et al. 2021

Acad Dermatol Venereol

View full text Add to dashboard Cite

Albinism is a worldwide genetic disorder caused by mutations in at least 20 genes, identified to date, that affect melanin production or transport in the skin, hair and eyes. Patients present with variable degrees of diffuse muco‐cutaneous and adnexal hypopigmentation, as well as ocular features including nystagmus, misrouting of optic nerves and foveal hypoplasia. Less often, albinism is associated with blood, immunological, pulmonary, digestive and/or neurological anomalies. Clinical and molecular characterizations are essential in preventing potential complications. Disease‐causing mutations remain unknown for about 25% of patients with albinism. These guidelines have been developed for the diagnosis and management of syndromic and non‐syndromic forms of albinism, based on a systematic review of the scientific literature. These guidelines comprise clinical and molecular characterization, diagnosis, therapeutic approach and management.

show abstract

Section: Neurological and Psychological Monitoringmentioning

confidence: 99%

Management of albinism: French guidelines for diagnosis and care

Moreno‐Artero

Morice‐Picard

Brémond‐Gignac

et al. 2021

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…27 Until confounding psychosocial factors are taken into account, the association between albinism and ADHD may not reflect reality. 28 Screening, diagnosis, and management of ADHD using psychoeducational and pharmacologic interventions should be considered based on history.…”

Section: Reading Abilitymentioning

confidence: 99%

Unseen Impairment: Pediatric Primary Care Management of Oculocutaneous Albinism 2

Kronick¹,

John²

2016

The Journal for Nurse Practitioners

View full text Add to dashboard Cite

Oculocutaneous albinism type 2 (OCA2), an autosomal recessive mutation of the OCA2 gene on chromosome 15, results in ocular and dermatologic manifestations. In primary care, nurse practitioners must detect the condition, refer to specialists, provide psychosocial support, refer to community resources, and coordinate care for children with this disorder. This article discusses the pathophysiology, epidemiology, and differential diagnosis of OCA2 as well as a discussion of the clinical implications and nurse practitioner management of the condition. The unique psychosocial effects of having the OCA2 mutation are less frequently explored in the current literature and are highlighted in this article.

show abstract

Does an Increased Prevalence Rate of Attention-Deficit Hyperactivity Disorder (ADHD) Exist Among Persons With Albinism?

Cited by 2 publications

References 18 publications

Management of albinism: French guidelines for diagnosis and care

Management of albinism: French guidelines for diagnosis and care

Unseen Impairment: Pediatric Primary Care Management of Oculocutaneous Albinism 2

Contact Info

Product

Resources

About